top of page
Search
Patent Review Reveals 133 Medicinal Mushroom Applications Targeting Cancer, Infections, and Neurodegenerative Disease
Too long to read? Go for the highlights below. Analysis of 133 patent filings between 2019-2024 shows mushroom-derived compounds targeting 14 therapeutic areas, with anticancer applications representing the largest cluster at 24 patents Ganoderma and Phellinus genera feature most prominently across filings, with Korea (43 patents), China (39), and the USA (27) leading global patenting activity Global medicinal mushroom market  projected to reach $59.41 billion by 2031 at 8.2%
Oct 18
Better Meat Co Secures Patent for Turning Potato Waste into Mycelium Protein
California-based food tech company The Better Meat Co has received its sixth US patent, this time for a method of growing mycelium...
Apr 17
Hypha Laboratories Reveals New Patent Applications for Novel Artificial Intelligence Driven In-Home Mycelium Production
Hypha Labs, Inc. (OTC PINK:DIGP), a pioneer in functional mushroom sciences, is pleased to announce the addition of significant...
Jul 17, 2024
Mycelium Leather Breakthrough: Spora's First Patent
Headquartered in Santiago, Chile, Spora has made significant strides in addressing climate change, animal abuse, and humanitarian issues...
Apr 27, 2024
bottom of page